Sooma depression treatment receives HSA approval in Singapore

Helsinki, Finland – December 12, 2017

Sooma Oy is proud to announce that it has received Singapore’s Health Sciences Authority (HSA) approval for its leading therapeutic platform Sooma tDCS. This approval allows Sooma and its distributor Equip Medical Pte Ltd to immediately market its products in Singapore.

Sooma Depression Treatment is a safe and effective treatment for major depressive disorder (MDD) delivered with an easy-to-use portable device. The therapy works by delivering a mild electrical current through electrodes placed on the head and relieving the symptoms of MDD.

Interested parties should contact Sooma Medical ( or Mr K. Jayaram at Equip Medical ( or / tel. +65 90 488355 for further information.

For availability information and distributor contacts in your country, please see: